Clinical trial
Obese Hypertension Study (0954-315)
NCT00289887 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00289887 |
|---|---|
| Title | Obese Hypertension Study (0954-315) |
| Official title | A Double-Blind, Randomized, Parallel, Efficacy Study Evaluating Losartan Potassium Alone or in Combination With Hydrochlorothiazide Versus Placebo in Obese Patients With Elevated Systolic and Diastolic Blood Pressure |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Comparator: losartan +/- HCTZ, Comparator: Placebo |
| Enrollment | 261 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Feb 10, 2006 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: